A New Way to Lose Weight

Meet Tirzepatide – a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor, and GLP-1 (glucagon-like peptide-1) receptor agonist, representing a new class of medicines studied for the treatment of obesity. Tirzepatide is a single peptide that triggers the body’s receptors for GIP and GLP-1, two natural incretin hormones.

Schedule Online Consult
How It Works

Terzepatide GIP promotes decreased food intake and increased energy expenditure, resulting in weight reductions. Combined with a GLP-1 receptor agonist, it has a more significant effect on glucose and body weight effects.

Benefits Include: Substantial A1C reductions. Boosted weight loss. Improvements in cardiometabolic measures. Reduce appetite.

Schedule Online Consult
Get Started Now

Terzepatide is an effective and safe weight loss treatment, but is only available in certain markets. For patients in California and Texas, we will advise the use of other GLP1 Medications such as semaglutidePatients in all other US States are eligible for treatment with terzepatide, semaglutide and other weight loss treatments.

Learn More
Schedule Online Consult